Jim Cramer noted that Teva Pharmaceuticals (TEVA)  cut their dividend and they're talking about pressure in U.S. generics. That's pretty interesting because that's the business that they bought from Allergan (AGN) . People just feel like it doesn't have the oomph but they did boost the forecast. 

Jim Cramer also noted that Teva is probably the weakest of the pharmaceuticals group.  

Watch all of Jim Cramer's latest videos, right here:

More from Video

If You Want to Invest in Artificial Intelligence, Here's the One Stock to Buy

If You Want to Invest in Artificial Intelligence, Here's the One Stock to Buy

Economist Perspective: Brexit Endgame in Sight?

Economist Perspective: Brexit Endgame in Sight?

Smaller Cap Stocks Could Make Great Stocking Stuffers Ahead of 2019

Smaller Cap Stocks Could Make Great Stocking Stuffers Ahead of 2019

5 Highly Anticipated Tech IPOs to Watch in 2019

5 Highly Anticipated Tech IPOs to Watch in 2019

Trading Strategies: How to Play the Federal Reserve's Decision Next Week

Trading Strategies: How to Play the Federal Reserve's Decision Next Week